BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Inscopix and ON Semiconductor Collaborate to Advance Brain Mapping Technology

  At the Society for Neuroscience conference this week, Inscopix is introducing the third-generation of its brain mapping system, nVista, incorporating the latest image sensor technology from ON Semiconductor.

  November 13, 2017

   · 

  2 min read
• BioCapital

  Immunomic Scientist Dr. Pratima Sinha to Speak at the International Conference on Vaccine Research and Development

  Immunomic present at the 3rd Annual International Conference on Vaccine Research and Development. Dr. Sinha will discuss her research employing LAMP technology in hopes of enhancing antitumor immunity.

  November 13, 2017

   · 

  2 min read
• Bio NC

  vTv to Host Key Opinion Leader Event to Discuss the Current State of Clinical Development in Alzheimer’s Disease

  vTv announced that the Company will host a key opinion leader (KOL) presentation and webcast focused on the current state of clinical development in Alzheimer’s disease in New York City on Thursday, November 16, 2017 from 8:00 am to 10:00 am ET.

  November 13, 2017

   · 

  5 min read
• Policy

  CEL-SCI Announces Update on Arbitration Against Former Clinical Research Organization

  The last witness in the arbitration hearing testified on Wednesday, November 8, 2017, and no further witnesses or testimony are expected.

  November 13, 2017

   · 

  3 min read
• Drug Development

  Array BioPharma Reports Initial Results From Novel Immunotherapy Combination at the SITC 32nd Annual Meeting

  Array BioPharma today announced data from the Phase Ib clinical trial evaluating the immunotherapy combination of ARRY-382, with Merck’s KEYTRUDA at the SITC 32nd Annual Meeting, being held Nov. 8-12, 2017 in National Harbor, Maryland.

  November 13, 2017

   · 

  6 min read
• Business

  Russo Partners Teams With Medovex to Highlight Medical Technology Innovation with DenerveX System for Treatment of Chronic Back Pain

  Russo Partners LLC and Medovex have teamed to call attention to the need for new treatments for chronic back pain and the Company’s innovative solution known as the DenerveX System.

  November 13, 2017

   · 

  4 min read
• Business

  Orexigen Therapeutics Announces Commercialization and Distributorship Agreement With Merck KGaA for Contrave in Latin America

  Under the terms of the agreement, Merck KGaA will be responsible for all commercialization and regulatory activities and will own marketing authorization in the region.

  November 13, 2017

   · 

  8 min read
• BioMidwest

  Stryker Announces Publication of the DAWN Trial Results in the New England Journal of Medicine

  The New England Journal of Medicine published the results of the DAWN Trial, the first to provide compelling evidence in treating late window and wake-up stroke patients with mechanical thrombectomy.

  November 13, 2017

   · 

  3 min read
• Business

  Zynex Announces 2017 Third Quarter Earnings

  The Company reported net revenue of $6.8M, an 88% increase over Q3-2016 and a 35% increase compared to Q2-2017.

  November 13, 2017

   · 

  18 min read
• Business

  Spruce Biosciences Appoints Camilla V. Simpson to Board of Directors

  Previously, Ms. Simpson was Group Vice President of Regulatory Affairs at BioMarin, and has 22 years of experience in the industry.

  November 13, 2017

   · 

  2 min read